Officials, scientists, and others agree that her close ties to Bush policies could cost the agency director her job More than ever before, the future direction and leadership of the National Institutes of Health will hinge on the outcome of a United States presidential election. There is strong feeling among many key congressional staffers and other Washington observers that NIH director Bernadine Healy, because she appears to be inextricably linked to the Bush administration and its policies,
Officials, scientists, and others agree that her close ties to Bush policies could cost the agency director her job |
Although early in her tenure, Healy was widely thought of as someone who would have remained at the agency's helm no matter who might be elected in the fall of 1992, times have changed.
Congressional aides, who are generally constrained from making attributed comments, were able to speak off the record for this article. According to one well-placed aide, Healy "had a halo" ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
